AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 33 filers reported holding AMBRX BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 1.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $274,694,949 | 44.91% |
| Cormorant Asset Management, LP | 9,616,155 | $158,281,911 | 8.87% |
| VR Adviser, LLC | 2,484,960 | $40,902,442 | 6.54% |
| COMMODORE CAPITAL LP | 3,175,000 | $52,260,500 | 5.87% |
| Paradigm Biocapital Advisors LP | 1,650,499 | $27,167,214 | 2.10% |
| Ghost Tree Capital, LLC | 238,225 | $3,921,184 | 1.29% |
| HighVista Strategies LLC | 153,431 | $2,525,474 | 1.16% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $559,640 | 0.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $1,646,000 | 0.51% |
| Artal Group S.A. | 702,291 | $11,560 | 0.36% |